Biocomposites welcomes new clinical pathway for local infection management in severe pressure ulcers

  • Independent Wounds UK Best Practice Statement provides a structured pathway for assessing and managing osteomyelitis in sacral pressure ulcers
  • Complementary expert report offers practical recommendations for using STIMULAN® with antibiotics in appropriately selected patients

Keele, UK, 17 November 2026 – Biocomposites, an international medical devices company that engineers, manufactures and markets world-leading products for use in infection management in bone and soft tissue, welcomes the publication of new clinical guidance from Wounds UK aimed at improving the assessment and treatment of osteomyelitis in patients with severe pressure ulcers.

Read more…

© Optimum Strategic Communications.